BMS-817378

CAS No. 1174161-69-3

BMS-817378( BMS817378 )

Catalog No. M10591 CAS No. 1174161-69-3

BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 106 Get Quote
5MG 156 Get Quote
10MG 232 Get Quote
25MG 422 Get Quote
50MG 618 Get Quote
100MG 881 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-817378
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.
  • Description
    BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.Solid Tumors Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS817378
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    c-Met/HGFR
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1174161-69-3
  • Formula Weight
    578.85
  • Molecular Formula
    C24H18ClF2N4O7P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=CC=C1C2=CN(C=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)COP(=O)(O)O)F
  • Chemical Name
    (Z)-N-(4-((3-chloro-2-imino-1,2-dihydropyridin-4-yl)oxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1-((phosphonooxy)methyl)-1,4-dihydropyridine-3-carbimidic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AHU377 calcium salt

    AHU-377 hemicalcium salt is a potent NEP inhibitor with an IC50 of 5 nM. AHU-377 is a component of the heart failure medicine LCZ696.AHU377 is a prodrug of LBQ657.

  • Foretinib

    Foretinib (XL880, GSK1363089, GSK089, EXEL-2880) is a potent, multikinase inhibitor that inhibits c-Met and VEGFR, also KIT, Flt-3, PDGFRβ, and Tie-2.

  • SAR125884

    SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).